99mTc bone scintigraphy superscans: A review

Nuclear Medicine Communications

Volumn 28, Issue 7, 2007, Pages 521-527

  Buckley, Orla ^a   O'Keeffe, Sylvia ^a   Geoghegan, Tony ^a   Lyburn, Ian D ^b   Munk, Peter L ^c   Worsley, Dan ^c   Torreggiani, William C ^a  

^a ADELAIDE AND MEATH HOSPITAL   (Ireland)

^b Department of Trauma and Orthopaedics Cheltenham Hospital   (United Kingdom)

^c VANCOUVER GENERAL HOSPITAL   (Canada)

Author keywords

Bone scintigraphy; Radionuclide scan; Superscan

Indexed keywords

OXIDRONATE TECHNETIUM TC 99M; TECHNETIUM 99M;

ANKYLOSING SPONDYLITIS; APLASTIC ANEMIA; BONE DISEASE; BONE DYSPLASIA; BONE SCINTISCANNING; BREAST CANCER; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; GOITER; HUMAN; HYPERPARATHYROIDISM; HYPERTHYROIDISM; LUNG CANCER; LYMPHOMA; MASTOCYTOSIS; METABOLIC BONE DISEASE; MYELOFIBROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOMALACIA; OSTEOPOROSIS; PAGET BONE DISEASE; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PROSTATE CANCER; RENAL OSTEODYSTROPHY; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL NOISE RATIO; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STOMACH CANCER; VITAMIN D INTOXICATION; WALDENSTROEM MACROGLOBULINEMIA;

BONE DISEASES; HUMANS; IMAGE ENHANCEMENT; RADIOPHARMACEUTICALS; TECHNETIUM; WHOLE BODY IMAGING;

EID: 34249820788     PISSN: 01433636     EISSN: None     Source Type: Journal    
DOI: 10.1097/MNM.0b013e3281744440     Document Type: Review

References (41)

1. 99mTc- diphosphonate bone scans and roentgenograms in the detection of prostate, breast and lung carcinoma metastases. Am J Roentgenol 1975; 125:972-977.
2. m(V)DMSA scintigraphy in skeletal metastases and superscans arising from various malignancies: diagnosis, treatment monitoring and therapeutic implications. Br J Radiol 2004; 77:347-361.
3. Massie JD, Sebes JI. The headless bone scan: an uncommon manifestation of metastatic superscan in carcinoma of the prostate. Skel Radiol 1988; 17:111-113.
4. Soloway MS, Hardeman SW. Stratification of patients with metastatic prostate cancer based on extent of disease on initial bone scan. Cancer 1988; 61:195-202.
5. Weckesser M, Muler-Mattheis VG. Pathogenic differentiation of the bone scan using bone marrow scintigraphy. Nuklearmedizin 1998; 37:156-183.
6. Liu RS, Chu YK, Chu LS, Yeh SH, Yen SH, Chen KY, et al. Superscan in patients with nasopharyngeal carcinoma. Clin Nucl Med 1996; 21:302-306.
7. Choi CW, Lee DS, Chung JK, Lee MC, Kim NK, Choi KW, Koh CS. Evaluation of bone metastases by Tc-99m MDP imaging in patients with stomach cancer. Clin Nucl Med 1995; 20:310-314.
8. Duncker CM, Carrio I. Radioimmune imaging of bone marrow in patients with suspected bone metastases from primary breast cancer. J Nucl Med 1990; 31:1450-1455.
9. Wiegman T, Rosenthall L, Kaye M. Technetium 99m pyrophosphate scans in hyperparathyroidism. J Nucl Med 1971; 18:231-235.
10. Winter PF, Johnson PM. Significance of renal visualization during bone scanning in Paget's disease. Nulearmedizin 1976; 15:131-134.
11. Sy WM, Mittal AK. Bone scan in chronic dialysis patients with evidence of secondary hyperparathyroidism and renal osteodystrophy. Br J Radiol 1975; 48:878-884.
12. Kim S, Park CH, Kim B. 'Superscan' in an autosomal dominant benign form of osteopetrosis. Clin Nucl Med 2001; 26:636-637.
13. Khour J, Jerushal J, Cohen HI, Loberan N, Zaina A. Super scan leading to definitive diagnosis in a patient with recurrent syncope. Clin Nucl Med 2003; 28:886-889.
14. Kim EE, De Land FH. Myelofibrosis presenting as hypermetabolic bone disease by radionuclide imaging in a patient with asplenia. Clin Nucl Med 1978; 3:406-408.
15. Frankel RS, Johnson KW, Mabry JJ, Johnston GS. 'Normal' bone radionuclide image with diffuse skeletal lymphoma. A case report. Radiology 1974; 111:365-366.
16. Cheng TH, Holman BL. Increased skeletal: renal uptake ratio. Radiology 1980; 136:455-459.
17. Fogelman I, Collier BD. Bone scintigraphy: Part 3. Bone scanning in metabolic bone disease. J Nucl Med 1993; 34:2247-2252.
18. Hyldstrup L, McNair P, Finn Jensen G, Borg Mogensen N, Transbol I. Measurements of whole body retention of diphosphonate and other indices of bone metabolism in 125 normals: dependency on age, sex and glomerular filtration. Scand J Clin Lab Invest 1984; 44:673-678.
19. Fogelman I, Bessent RG, Turner JH, Citrin FL, Boyle IT, Greig WR. The use of whole body retention of Tc-99m diphosphonate in the diagnosis of metabolic bone disease. J Nucl Med 1978; 19:270-275.
20. Constable AR, Cranage RW. Recognition of the superscan in prostatic bone scintigraphy. Br J Radiology 1981; 54:122-125.
21. Kim SE, Kim DY, Kim SE. Absent or faint renal uptake on bone scan. Clin Nucl Med 1991; 16:545-549.
22. Swislocki AL, Barnett CA, Darnell P, Noth RH. Hyperthyroidism: an underappreciated cause of diffuse bone disease. Clin Nucl Med 1998; 23:241-243.
23. Manier SM, Stadalnik RC. Super bone scan. Semin Nucl Med 1984; 16:46-47.
24. Benitez A, Torres M. Radionuclide bone scanning in patients with breast carcinoma. Rev Esp Med Nucl 1998; 17:435-441.
25. Han R, Nikpoor N. Different scintigraphic patterns of superscan [Abstract]. AJR, Am J Roentgenol 2006; 186:A145-A148.
26. Fogelman I, Carr D, Boyle IT. The role of bone scanning in Paget's disease. Metab Bone Relat Res 1981; 3:243-254.
27. Whyte MP. Paget's disease of bone. N Engl J Med 2006; 355:593-599.
28. Haubold-Reuter BG, Duewell S, Schilcher BR, Marincek B, von Schulthess GK. Fast spin echo MRI and bone scintigraphy in the detection of skeletal metastases. Eur Radiol 1993; 3:316-320.
29. Frank JA, Ling A, Patronas NJ, Carrasquillo JA, Horvath K, Hickey AM, Dwyer AJ. Detection of malignant bone tumours: MR imaging versus scintigraphy. Am J Roentgenol 1990; 155:1043-1048.
30. Fujimoto R, Higashi T, Nakamoto Y, Hara T, Lyshchik A, Ishizu K, et al. Diagnostic accuracy of bone metastases detection in cancer patients: comparison between bone scintigraphy and whole-body FDG-PET. Ann Nucl Med 2006; 20:399-408.
31. Tian M, Zhang H, Endo K. Whole-body FDG-PET versus Tc-99m MDP bone scintigraphy for detection of bone metastases in patients with lung cancer [Abstract]. J Clin Oncol 2005; 23(16S):2023.
32. Fogelman I, Cook G, Israel O, Van der Wall H. Positron emission tomography and bone metastases. Semin Nucl Med 2005; 35:135-142.
33. 18F]fluoride ion in renal osteodystrophy: correlation with bone histomorphometry. J Clin Endocrinol Metab 1993; 77:949-955.
34. 18F-Fluoride PET for monitoring therapeutic response in Paget's disease of bone. J Nucl Med 2005; 46:1650-1658.
35. Su HY, Liu RS, Liao SQ, Wang SJ. F-18 FDG PET superscan. Clin Nucl Med 2006; 31:28-29.
36. Berna G, Torres G. Antigranulocyte antibody bone marrow scans in cancer patients with metastatic bone superscan appearance. Clin Nucl Med 1994; 19:121-128.
37. Siddiqui AR, Oseas RS, Wellman HN, Doerr DR, Baehner RL. Evaluation of bone-marrow scanning with technetium-99m sulfur colloid in pediatric oncology. J Nucl Med 1978; 2:379-386.
38. Love C, Din AS, Tomas MB, Kalapparambath TP, Palestro CJ. Radionuclide bone imaging: An illustrative review. Radiographics 2003; 23:341-358.
39. Kajubi SK, Chayes ZW. Superscan prediction - another benefit of early renal views in bone scans. J Nucl Med 1985; 26:428-429.
40. Gates GF. SPECT bone scanning of the spine. Semin Nucl Med 1998; 28:78-94.
41. Sarikaya I, Sarikaya I. The role of single photon emission computed tomography in bone imaging. Semin Nucl Med 2001; 31:3-16.